Log in to save to my catalogue

Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in tr...

Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in tr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9519646

Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients

About this item

Full title

Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Archives of gynecology and obstetrics, 2022-11, Vol.306 (5), p.1689-1695

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
PD-L1 receptor expression in breast cancer tissue can be assessed with different anti-human PD-L1 monoclonal antibodies. The performance of three specific monoclonal antibodies in a head-to-head comparison is unknown. In addition, a potential correlation of PD-L1 expression and clinico-pathological parameters has not been investigated...

Alternative Titles

Full title

Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9519646

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9519646

Other Identifiers

ISSN

1432-0711,0932-0067

E-ISSN

1432-0711

DOI

10.1007/s00404-022-06529-w

How to access this item